Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy.

Liu G, Berlin J, Tutsch KD, Van Ummersen L, Dresen A, Marnocha R, Arzomanian R, Alberti D, Feierabend C, Binger K, Wilding G
Clin Cancer Res. 2002 8 (3): 706-11

PMID: 11895899

MeSH Terms (15)

Administration, Oral Adult Aged Aged, 80 and over Antineoplastic Agents Cerebellar Ataxia Dizziness Female Humans Male Maximum Tolerated Dose Middle Aged Nausea Neoplasms Picolines

Connections (1)

This publication is referenced by other Labnodes entities: